Single names, sectors, valuations and the trades behind the tape, explained in plain language.

Nestlé says some parents may not return after pulling baby formula over possible cereulide contamination. The food giant warns it could take

US movie theaters are set for their best post-COVID second quarter, with June ticket sales projected at $1.05 billion. However, AMC's latest

Sucro shares surged 13% after the company launched a strategic review to explore value-unlocking options like asset sales, joint ventures, a

Biodexa Pharmaceuticals has priced a three-part fundraise worth $3.5 million, combining a registered offering, private placement, and warran

Bank of America Securities downgraded Fox Factory to underperform, arguing its cost-cut push may not be enough to lift 2026 earnings much. T

Pyxis Oncology is raising up to $114 million via a private placement, securing $50 million upfront to advance its drug candidate Micvo. The

Nestlé will remove artificial colors from all its products globally by 2026, after years of R&D. The shift responds to consumer demand for c

Cencora chair Mark Durcan bought 4,000 shares worth about $1 million after the stock fell following Q2 earnings. The purchase, flagged as un

QXO is finalizing its acquisition of TopBuild, aiming for a July 1 close. Most TopBuild holders elected cash, but proration rules mean the p

Oppenheimer downgraded Goldman Sachs and Morgan Stanley, saying their valuations look stretched. The brokerage prefers alternative asset man

The UK government is weighing whether to intervene in the $110 billion Paramount-Skydance deal for Warner Bros Discovery. Culture minister L

Quarterhill is buying Conduent's tolling unit for $70 million in cash and stock. The deal, closing in Q4 2026, could create a combined backl